Europe’s medical devices industry saw a drop of 2.56% in deal activity during April 2022, when compared with the last 12-month average, led by Wallaby Medical’s $541.63m acquisition of Phenox, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 38 medical devices industry deals worth $1.1bn were announced for the region in April 2022, against the 12-month average of 39 deals.
Of all the deal types, venture financing saw most activity in April 2022 with 21 transactions, representing a 55.3% share for the region.
In second place was M&A with 12 deals, followed by private equity deals with five transactions, respectively capturing a 31.6% and 13.2% share of the overall deal activity for the month.
In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $883.29m, while venture financing and private equity deals totalled $185.37m and $10.85m, respectively.
Europe medical devices industry deals in April 2022: Top deals
The top five medical devices deals accounted for 84.3% of the overall value during April 2022.
The combined value of the top five medical devices deals stood at $910.25m, against the overall value of $1.1bn recorded for the month.
The top five medical devices industry deals of April 2022 tracked by GlobalData were:
1) Wallaby Medical $541.63m acquisition deal with Phenox
2) The $141.73m acquisition of Aran Biomedical by Integer
3) Cochlear $122.03m acquisition deal with Oticon Medical
4) The $54.73m venture financing of Avi Medical by 3VC Partners,Balderton Capital,Eurazeo,heal.capital Management,Picus Capital and Vorwerk Ventures
5) SD Biosensor $50.14m acquisition deal with Relab